GOLD DANIEL ALLEN sold 9.4% of their position (1.69M shares) of ROIVANT SCIENCES LTD. on the open market
Open‑market sale worth $39.07M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 12/18/2025ACC: 0001193125-25-325359
-1.69M
Net shares
Net seller
$39.07M
Total sold
5
Open market trades
0B · 5S
5
Total transactions
1.69M disposed
Non-Derivative Transactions5
Common Shares
Indirect
Shares
−275K
Price / share
$22.93
Trade value
$6.31M
% of position
1.5%
12/16/2025
18.05M→17.77M
Common Shares
Indirect
Shares
−642.28K
Price / share
$23.08
Trade value
$14.82M
% of position
3.6%
12/16/2025
17.77M→17.13M
Common Shares
Indirect
Shares
−432.72K
Price / share
$23.05
Trade value
$9.97M
% of position
2.5%
12/17/2025
17.13M→16.70M
Common Shares
Indirect
Shares
−155.08K
Price / share
$23.02
Trade value
$3.57M
% of position
0.9%
12/17/2025
16.70M→16.54M
Common Shares
Indirect
Shares
−189.54K
Price / share
$23.17
Trade value
$4.39M
% of position
1.1%
12/17/2025
16.54M→16.35M
Total
Net shares
−1.69M
Net value
-$39.07M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Indirect | 12/16/2025 | S · Sale | −275K | $22.93 | $6.31M | 1.5% | 18.05M | 17.77M |
| Common Shares Indirect | 12/16/2025 | S · Sale | −642.28K | $23.08 | $14.82M | 3.6% | 17.77M | 17.13M |
| Common Shares Indirect | 12/17/2025 | S · Sale | −432.72K | $23.05 | $9.97M | 2.5% | 17.13M | 16.70M |
| Common Shares Indirect | 12/17/2025 | S · Sale | −155.08K | $23.02 | $3.57M | 0.9% | 16.70M | 16.54M |
| Common Shares Indirect | 12/17/2025 | S · Sale | −189.54K | $23.17 | $4.39M | 1.1% | 16.54M | 16.35M |
| Total | −1.69M | -$39.07M | ||||||
Derivative Transactions0
No derivative transactions reported